Published in Am J Med on April 01, 1978
The life and times of the Enterococcus. Clin Microbiol Rev (1990) 16.58
Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010. Gastroenterology (2015) 1.69
Problems of bacterial infection in patients with liver disease. Gut (1987) 1.47
Temperature and host defense. Microbiol Rev (1979) 1.35
Spontaneous bacterial peritonitis due to a group IIk-2 strain. J Clin Microbiol (1980) 1.30
Is fever beneficial? Yale J Biol Med (1986) 1.24
Clinical review: fever in septic ICU patients--friend or foe? Crit Care (2011) 1.21
Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good. Front Psychol (2012) 1.20
Fever management in intensive care patients with infections. Crit Care (2014) 1.06
Primary and secondary peritonitis: an update. Eur J Clin Microbiol Infect Dis (1998) 0.99
Spontaneous bacterial peritonitis: a review of treatment options. P T (2009) 0.98
Influence of body temperature on bacterial growth rates in experimental pneumococcal meningitis in rabbits. Infect Immun (1986) 0.95
Fever: is it beneficial? Yale J Biol Med (1986) 0.93
Febrile-range hyperthermia augments lipopolysaccharide-induced lung injury by a mechanism of enhanced alveolar epithelial apoptosis. J Immunol (2010) 0.90
Nontypeable Haemophilus influenzae as a cause of spontaneous bacterial peritonitis. J Clin Microbiol (2006) 0.87
Use of the delta neutrophil index as a prognostic factor of mortality in patients with spontaneous bacterial peritonitis: implications of a simple and useful marker. PLoS One (2014) 0.87
Fever, hyperthermia, and the lung: it's all about context and timing. Trans Am Clin Climatol Assoc (2011) 0.85
Is fever suppression involved in the etiology of autism and neurodevelopmental disorders? BMC Pediatr (2003) 0.85
Spontaneous peritonitis due to group B streptococci. Can Med Assoc J (1979) 0.81
Spontaneous bacterial peritonitis: Analysis of treatment and outcome. Can J Infect Dis (1991) 0.79
Organisms causing spontaneous bacterial peritonitis in children with liver disease and ascites in Southern Iran. World J Gastroenterol (2006) 0.78
Hyperthermic enhancement of serum antimicrobial activity: mechanism by which fever might exert a beneficial effect on the outcome of gram-negative sepsis. Infect Immun (1983) 0.78
What We Do When We Suppress Fever. Curr Infect Dis Rep (2005) 0.77
Elevated body temperature restricts growth of Haemophilus influenzae type b during experimental meningitis. Infect Immun (1992) 0.77
Distribution of ciprofloxacin in ascitic fluid following administration of a single oral dose of 750 milligrams. Antimicrob Agents Chemother (1992) 0.77
Spontaneous bacterial peritonitis due to Campylobacter jejuni. Postgrad Med J (1984) 0.77
Radioimmunoassay and opsonic antibody responses to pneumococcal capsular polysaccharide vaccine in serum and ascitic fluid of cirrhotic patients. J Clin Microbiol (1983) 0.76
Nonpharmacologic approach to minimizing shivering during surface cooling: a proof of principle study. J Crit Care (2012) 0.76
Spontaneous peritonitis caused by Enterococcus faecium. J Clin Microbiol (1990) 0.75
Cordelia, Goneril and the febrile response. Trans Am Clin Climatol Assoc (1997) 0.75
Infections caused by group F streptococci. Can Med Assoc J (1981) 0.75
The efficacy and safety profile of albumin administration for patients with cirrhosis at high risk of hepatorenal syndrome is dose dependent. Gastroenterol Rep (Oxf) (2015) 0.75
Peritoneal fluid concentrations of gentamicin in patients with spontaneous bacterial peritonitis. Antimicrob Agents Chemother (1981) 0.75
Outcomes of transjugular intrahepatic portosystemic shunts for ascites. Semin Intervent Radiol (2014) 0.75
Euthermic endocarditis. PLoS One (2013) 0.75
Effect of protein malnutrition on salmonellosis and fever. Infect Immun (1988) 0.75
The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis (1983) 10.03
Nosocomial klebsiella infections: intestinal colonization as a reservoir. Ann Intern Med (1971) 6.55
Controlled evaluation of the volume of blood cultured in detection of bacteremia and fungemia. J Clin Microbiol (1982) 6.19
Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol (1999) 5.83
Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion (1999) 5.67
Controlled comparison of the BacT/Alert and BACTEC 660/730 nonradiometric blood culture systems. J Clin Microbiol (1992) 5.09
The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis (1983) 4.52
Update on detection of bacteremia and fungemia. Clin Microbiol Rev (1997) 4.01
Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests. J Infect Dis (1977) 4.00
Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother (1983) 3.83
5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience. Ann Intern Med (1972) 3.55
Infectious complications in renal transplant recipients. Transplant Proc (1973) 3.26
Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent. J Infect Dis (1977) 3.15
The Klebsiella-Enterobacter-Serratia division. Biochemical and serologic characteristics and susceptibility to antibiotics. Ann Intern Med (1966) 3.07
The Klebsiella-Enterobacter-Serratia division. Clinical and epidemiologic characteristics. Ann Intern Med (1966) 2.92
CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens. Neurology (2001) 2.88
Development of a standardized screening method for detection of vancomycin-resistant enterococci. J Clin Microbiol (1994) 2.77
Controlled evaluation of BACTEC Plus 26 and Roche Septi-Chek aerobic blood culture bottles. J Clin Microbiol (1991) 2.62
Controlled clinical laboratory comparison of BACTEC plus aerobic/F resin medium with BacT/Alert aerobic FAN medium for detection of bacteremia and fungemia. J Clin Microbiol (1997) 2.54
In vitro effects of carbenicillin combined with gentamicin or polymyxin B against Pseudomonas aeruginosa. Appl Microbiol (1969) 2.43
Molecular epidemiology of macrolides-lincosamides-streptogramin B resistance in Staphylococcus aureus and coagulase-negative staphylococci. Antimicrob Agents Chemother (1987) 2.39
Prevalence of macrolides-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci. Antimicrob Agents Chemother (1987) 2.35
Controlled evaluation of BacT/alert standard anaerobic and FAN anaerobic blood culture bottles for the detection of bacteremia and fungemia. J Clin Microbiol (1995) 2.21
Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative. Antimicrob Agents Chemother (1981) 2.11
Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. Am J Epidemiol (1990) 2.06
In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin. Antimicrob Agents Chemother (1976) 2.04
Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. Antimicrob Agents Chemother (1981) 2.04
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol (1993) 2.00
Controlled evaluation of the agar-slide and radiometric blood culture systems for the detection of bacteremia and fungemia. J Clin Microbiol (1986) 1.98
Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol (1994) 1.97
Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine. Antimicrob Agents Chemother (Bethesda) (1970) 1.97
Epidemiology of Legionnaires' disease. Ann Intern Med (1979) 1.97
Controlled evaluation of BACTEC PLUS 27 and Roche Septi-Chek anaerobic blood culture bottles. J Clin Microbiol (1992) 1.92
Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J Med (1985) 1.92
Rapid sulfonamide disc sensitivity test for meningococci. Appl Microbiol (1968) 1.87
Pseudomonas pseudomallei: susceptibility to chemotherapeutic agents. J Infect Dis (1970) 1.86
An outbreak in 1965 of severe respiratory illness caused by the Legionnaires' disease bacterium. J Infect Dis (1978) 1.84
Recovery of clinically important microorganisms from the BacT/Alert blood culture system does not require testing for seven days. Diagn Microbiol Infect Dis (1993) 1.83
Controlled evaluation of the effect of atmosphere of incubation on detection of bacteremia and fungemia in supplemented peptone broth. J Clin Microbiol (1982) 1.81
Differentiation of beta-lactamase variants of Staphylococcus aureus by substrate hydrolysis profiles. J Infect Dis (1989) 1.80
Surveillance of nosocomial infections in community hospitals. I. Surveillance methods, effectiveness, and initial results. J Infect Dis (1969) 1.80
Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. Clin Infect Dis (1997) 1.76
Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections. J Pediatr (1971) 1.75
Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration. J Infect Dis (1982) 1.74
Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis (1983) 1.72
Effects of ampicillin-amikacin and ampicillin-rifampin on enterococci. Antimicrob Agents Chemother (1976) 1.71
Bacillus cereus pneumonia and bacteremia. A case report. Am Rev Respir Dis (1971) 1.70
Comparison of the Staph-Ident system with a conventional method for species identification of urine and blood isolates of coagulase-negative staphylococci. J Clin Microbiol (1983) 1.66
Immunization against influenza: rationale and recommendations. J Infect Dis (1971) 1.65
Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. J Infect Dis (1996) 1.63
In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine, and clotrimazole (Bay 5097). Appl Microbiol (1971) 1.60
Use of extracts versus whole-cell bacterial suspensions in the identification of Staphylococcus aureus beta-lactamase variants. Antimicrob Agents Chemother (1990) 1.59
Reassuring safety profile of moxifloxacin. Clin Infect Dis (2001) 1.52
Cerebrospinal fluid shunt infections with anaerobic diphtheroids (Propionibacterium species). J Neurosurg (1976) 1.51
Outbreak of a multiply resistant Acinetobacter in a surgical intensive care unit: epidemiology and control. Heart Lung (1978) 1.49
Letter: The issue of prophylaxis of neonatal group B streptococcal infections. J Pediatr (1973) 1.48
Carbenicillin: a clinical and laboratory evaluation. Ann Intern Med (1970) 1.48
In-vitro and in-vivo studies of resistance to rifampin in meningococci. J Infect Dis (1971) 1.46
Relevance of the number of positive bottles in determining clinical significance of coagulase-negative staphylococci in blood cultures. J Clin Microbiol (2001) 1.45
Protection against Hong Kong influneza by adjuvant vaccine containing A2-Ann Arbor-67. Bull World Health Organ (1969) 1.44
Characterization of four beta-lactamases produced by Staphylococcus aureus. Antimicrob Agents Chemother (1992) 1.41
Automated blood culture systems. Clin Lab Med (1994) 1.40
Thermonuclease test for same-day identification of Staphylococcus aureus in blood cultures. J Clin Microbiol (1985) 1.40
The expanding horizons of infection control. Infect Control Hosp Epidemiol (1995) 1.39
Clinical importance of increased sensitivity of BacT/Alert FAN aerobic and anaerobic blood culture bottles. J Clin Microbiol (1996) 1.39
Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. Clin Infect Dis (1996) 1.38
Unusual occurrence of neonatal meningitis due to group B beta-hemolytic streptococci. Pediatrics (1966) 1.37
Controlled evaluation of Trypticase soy broth in agar slide and conventional blood culture systems. J Clin Microbiol (1985) 1.35
Efficacy of "Hong Kong" vaccine in preventing "England" variant influenza A in 1972. N Engl J Med (1973) 1.33
Clinical comparison of an agar slide blood culture bottle with tryptic soy broth and a conventional blood culture bottle with supplemented peptone broth. J Clin Microbiol (1985) 1.33
Infectious risk factors in the immunosuppressed host. Am J Med (1973) 1.33
Antigenic drift and efficacy of influenza virus vaccines, 1976--1977. J Infect Dis (1978) 1.32
Staphylococcus hominis subsp. novobiosepticus subsp. nov., a novel trehalose- and N-acetyl-D-glucosamine-negative, novobiocin- and multiple-antibiotic-resistant subspecies isolated from human blood cultures. Int J Syst Bacteriol (1998) 1.31
Controlled evaluation of blood culture medium containing gelatin and V-factor-analog for detection of septicemia in children. J Clin Microbiol (1988) 1.28
Anogenital infection with Neisseria meningitidis in homosexual men. J Infect Dis (1978) 1.27
Multidrug-resistant Proteus rettgeri: an emerging problem. Ann Intern Med (1976) 1.27
Controlled clinical comparison of BacT/alert FA plus and FN plus blood culture media with BacT/alert FA and FN blood culture media. J Clin Microbiol (2013) 1.25
Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci. J Clin Microbiol (1995) 1.25
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies. Antimicrob Agents Chemother (1987) 1.23
Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis. Clin Infect Dis (1996) 1.22
RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn Microbiol Infect Dis (1993) 1.20
In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 1.19
Extensive diversity of branched-RNA-linked multicopy single-stranded DNAs in clinical strains of Escherichia coli. Proc Natl Acad Sci U S A (1989) 1.18
The current status of BCG immunization against tuberculosis. Annu Rev Med (1977) 1.18
Laboratory diagnosis of bacteremia and fungemia. Infect Dis Clin North Am (2001) 1.17
Bacteremia due to Clostridium difficile: case report and review of extraintestinal C. difficile infections. Clin Infect Dis (1995) 1.17
Update on blood cultures: how to obtain, process, report, and interpret. Clin Microbiol Infect (2013) 1.16
Bacteremic Pseudomonas pneumonia. JAMA (1974) 1.15
Antibiotic susceptibility of Bacillus species. J Infect Dis (1971) 1.13
Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis. Am J Med (1987) 1.10
Torulopsis glabrata--an opportunistic pathogen in man. N Engl J Med (1970) 1.10
Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods. J Clin Microbiol (2004) 1.10